Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)

  1. Lluch, A.
  2. Barrios, C.H.
  3. Torrecillas, L.
  4. Ruiz-Borrego, M.
  5. Bines, J.
  6. Segalla, J.
  7. Guerrero-Zotano, Á.
  8. García-Sáenz, J.A.
  9. Torres, R.
  10. de la Haba, J.
  11. García-Martínez, E.
  12. Gómez, H.L.
  13. Llombart, A.
  14. Bofill, J.S.
  15. Baena-Cañada, J.M.
  16. Barnadas, A.
  17. Calvo, L.
  18. Pérez-Michel, L.
  19. Ramos, M.
  20. Fernández, I.
  21. Rodríguez-Lescure, Á.
  22. Cárdenas, J.
  23. Vinholes, J.
  24. Martínez de Dueñas, E.
  25. Godes, M.J.
  26. Seguí, M.A.
  27. Antón, A.
  28. López-Álvarez, P.
  29. Moncayo, J.
  30. Amorim, G.
  31. Villar, E.
  32. Reyes, S.
  33. Sampaio, C.
  34. Cardemil, B.
  35. Escudero, M.J.
  36. Bezares, S.
  37. Carrasco, E.
  38. Martín, M.
  39. Show all authors +
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Year of publication: 2020

Volume: 38

Issue: 3

Pages: 203-213

Type: Article

DOI: 10.1200/JCO.19.00904 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus